niemann pick krankheit

Zevra Therapeutics Validates Key Clinical Scale for Niemann-Pick Disease Treatment Study | ZVRA Stock News

StockTitan - 11 Nov 2024
Zevra Therapeutics Validates Key Clinical Scale for Niemann-Pick Disease Treatment Study | ZVRA Stock News ...

Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C

StockTitan - 20 Sep 2024
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C ...

FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C

StockTitan - 02 Aug 2024
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C ...

XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News

StockTitan - 07 Nov 2024
XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News ...

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates

StockTitan - 12 Nov 2024
Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates ...

Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

StockTitan - 22 Aug 2024
Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement ...